November 9th 2024
Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for pharmaceutical manufacturing.
September 1st 2024
Sartorius Supports ABL Europe in Viral Vector GMP Capacity Expansion
March 19th 2018Sartorius has delivered to ABL’s Strasbourg facility, a GMP viral vector manufacturing package solution that includes single-use bioreactors and an automation platform for normal flow filtration, tangential filtration, and mixing.